Table 3.
Cure rates by age group within each trial arm at D14 and 28.
| Age (y) | D14 | D28 | ||||
|---|---|---|---|---|---|---|
| A. annua n/Na (%)b | A. afra n/N (%) | ASAQ n/N (%) | A. annua n/N (%) | A. afra n/N (%) | ASAQ n/N (%) | |
| 5–15 | 93/102 | 36/51 | 51/105 | 93/102 | 42/51 | 52/105 |
| (91.2%) | (70.6%) | (48.6%) | (91.2%) | (82.4%) | (49.5%) | |
| 16–65 | 146/146 | 145/172 | 110/367 | 146/146 | 156/172 | 110/367 |
| (100.0%) | (84.3%) | (30.0%) | (100.0%) | (90.7%) | (30.0%) | |
| Overall | 239/248 | 181/223 | 161/472 | 239/248 | 198/223 | 162/472 |
| (96.4%) | (81.2%) | (34.1%) | (96.4%) | (88.8%) | (34.3%) | |
N, total number within age group less any who left the trial; n, number with 0 parasitemia.
(%), n/N × 100.